Table 1.
No. | Age/Sex | Site | Symptoms | Size | Histology | Ep | CK | EMA | Pleo | Ch Ef | Surgery | Follow up |
1 | 27 M | Humerus | Pain | 8 | Os | + | 2+ | – | 2+ | Poor | Wide | 113 m, NED |
2 | 43 M | Ilium | Pain | 12 | Os | + | 2+ | – | + | Poor | Wide | 24 m, DOD |
3 | 28 M | Humerus | Pain | 4 | Fi | – | 2+ | – | 2+ | Poor | Wide | 38 m, AWD |
4 | 66 F | Femur | Pain | 11 | Os | + | 2+ | – | 2+ | Wide | 30 m, NED | |
5 | 18 M | Tibia | Pain | 6 | Fi | – | 2+ | – | 2+ | Poor | Wide | 319 m, NED |
6 | 13 F | Tibia | Pain | 8 | Chon | – | 2+ | – | + | Poor | Wide | 53 m, AWD |
Size, size (cm); Ep, epithelioid feature; CK, cytokeratin; EMA, epithelial membrane antigen; Pleo, pleomorphism; Ch Ef, chemotherapy effect; OS, osteoblastic; Fi, fibroblastic; Chon, chondroblastic; NED, no evidence of disease; DOD, dead of disease; AWD, alive with disease.